vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and ICHOR HOLDINGS, LTD. (ICHR). Click either name above to swap in a different company.
ICHOR HOLDINGS, LTD. is the larger business by last-quarter revenue ($256.1M vs $236.8M, roughly 1.1× CROSS COUNTRY HEALTHCARE INC). ICHOR HOLDINGS, LTD. runs the higher net margin — -1.0% vs -35.0%, a 34.1% gap on every dollar of revenue. On growth, ICHOR HOLDINGS, LTD. posted the faster year-over-year revenue change (4.7% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $-10.0M). Over the past eight quarters, ICHOR HOLDINGS, LTD.'s revenue compounded faster (12.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Ichor Holdings Ltd. designs, manufactures and supplies critical fluid delivery systems, subsystems and related components for the global semiconductor manufacturing sector. Its products are integrated into front-end wafer processing equipment, supporting production of advanced logic, memory and specialty chips for leading semiconductor device and equipment makers across North America, East Asia and Europe.
CCRN vs ICHR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $256.1M |
| Net Profit | $-82.9M | $-2.5M |
| Gross Margin | — | 12.6% |
| Operating Margin | -30.2% | 88.2% |
| Net Margin | -35.0% | -1.0% |
| Revenue YoY | -23.6% | 4.7% |
| Net Profit YoY | -2109.7% | 45.8% |
| EPS (diluted) | $-2.56 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $256.1M | ||
| Q4 25 | $236.8M | $223.6M | ||
| Q3 25 | $250.1M | $239.3M | ||
| Q2 25 | $274.1M | $240.3M | ||
| Q1 25 | $293.4M | $244.5M | ||
| Q4 24 | $309.9M | $233.3M | ||
| Q3 24 | $315.1M | $211.1M | ||
| Q2 24 | $339.8M | $203.2M |
| Q1 26 | — | $-2.5M | ||
| Q4 25 | $-82.9M | $-16.0M | ||
| Q3 25 | $-4.8M | $-22.9M | ||
| Q2 25 | $-6.7M | $-9.4M | ||
| Q1 25 | $-490.0K | $-4.6M | ||
| Q4 24 | $-3.8M | $-3.9M | ||
| Q3 24 | $2.6M | $-2.8M | ||
| Q2 24 | $-16.1M | $-5.1M |
| Q1 26 | — | 12.6% | ||
| Q4 25 | — | 9.4% | ||
| Q3 25 | 20.4% | 4.6% | ||
| Q2 25 | 20.4% | 11.3% | ||
| Q1 25 | 20.0% | 11.7% | ||
| Q4 24 | — | 11.6% | ||
| Q3 24 | 20.4% | 13.2% | ||
| Q2 24 | 20.8% | 12.6% |
| Q1 26 | — | 88.2% | ||
| Q4 25 | -30.2% | -6.2% | ||
| Q3 25 | -2.4% | -8.1% | ||
| Q2 25 | -2.1% | -2.0% | ||
| Q1 25 | -0.3% | -0.5% | ||
| Q4 24 | -1.1% | -0.5% | ||
| Q3 24 | 0.9% | -0.2% | ||
| Q2 24 | -5.7% | -1.1% |
| Q1 26 | — | -1.0% | ||
| Q4 25 | -35.0% | -7.1% | ||
| Q3 25 | -1.9% | -9.6% | ||
| Q2 25 | -2.4% | -3.9% | ||
| Q1 25 | -0.2% | -1.9% | ||
| Q4 24 | -1.2% | -1.7% | ||
| Q3 24 | 0.8% | -1.3% | ||
| Q2 24 | -4.7% | -2.5% |
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $-2.56 | $-0.46 | ||
| Q3 25 | $-0.15 | $-0.67 | ||
| Q2 25 | $-0.20 | $-0.28 | ||
| Q1 25 | $-0.02 | $-0.13 | ||
| Q4 24 | $-0.13 | $-0.11 | ||
| Q3 24 | $0.08 | $-0.08 | ||
| Q2 24 | $-0.47 | $-0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $89.1M |
| Total DebtLower is stronger | — | $6.3M |
| Stockholders' EquityBook value | $322.8M | $668.0M |
| Total Assets | $449.0M | $972.5M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $89.1M | ||
| Q4 25 | $108.7M | $98.3M | ||
| Q3 25 | $99.1M | $92.5M | ||
| Q2 25 | $81.2M | $92.2M | ||
| Q1 25 | $80.7M | $109.3M | ||
| Q4 24 | $81.6M | $108.7M | ||
| Q3 24 | $64.0M | $116.4M | ||
| Q2 24 | $69.6M | $114.3M |
| Q1 26 | — | $6.3M | ||
| Q4 25 | — | $123.5M | ||
| Q3 25 | — | $123.5M | ||
| Q2 25 | — | $125.0M | ||
| Q1 25 | — | $126.8M | ||
| Q4 24 | — | $128.5M | ||
| Q3 24 | — | $130.3M | ||
| Q2 24 | — | $130.2M |
| Q1 26 | — | $668.0M | ||
| Q4 25 | $322.8M | $663.9M | ||
| Q3 25 | $408.1M | $676.2M | ||
| Q2 25 | $412.2M | $694.1M | ||
| Q1 25 | $418.2M | $700.4M | ||
| Q4 24 | $419.0M | $698.3M | ||
| Q3 24 | $424.7M | $697.3M | ||
| Q2 24 | $433.3M | $694.9M |
| Q1 26 | — | $972.5M | ||
| Q4 25 | $449.0M | $942.9M | ||
| Q3 25 | $538.2M | $966.6M | ||
| Q2 25 | $553.8M | $985.1M | ||
| Q1 25 | $576.2M | $1.0B | ||
| Q4 24 | $589.3M | $995.6M | ||
| Q3 24 | $597.4M | $975.9M | ||
| Q2 24 | $602.9M | $947.7M |
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | $-10.0M |
| FCF MarginFCF / Revenue | 6.8% | -3.9% |
| Capex IntensityCapex / Revenue | 0.9% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $9.2M | ||
| Q3 25 | $20.1M | $9.2M | ||
| Q2 25 | $4.2M | $-7.5M | ||
| Q1 25 | $5.7M | $19.0M | ||
| Q4 24 | $24.2M | $-2.5M | ||
| Q3 24 | $7.5M | $8.1M | ||
| Q2 24 | $82.4M | $17.5M |
| Q1 26 | — | $-10.0M | ||
| Q4 25 | $16.1M | $5.9M | ||
| Q3 25 | $17.9M | $2.1M | ||
| Q2 25 | $2.3M | $-14.8M | ||
| Q1 25 | $3.8M | $496.0K | ||
| Q4 24 | $21.7M | $-6.9M | ||
| Q3 24 | $6.3M | $2.2M | ||
| Q2 24 | $79.6M | $14.6M |
| Q1 26 | — | -3.9% | ||
| Q4 25 | 6.8% | 2.6% | ||
| Q3 25 | 7.2% | 0.9% | ||
| Q2 25 | 0.8% | -6.2% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 7.0% | -3.0% | ||
| Q3 24 | 2.0% | 1.0% | ||
| Q2 24 | 23.4% | 7.2% |
| Q1 26 | — | 2.8% | ||
| Q4 25 | 0.9% | 1.5% | ||
| Q3 25 | 0.9% | 3.0% | ||
| Q2 25 | 0.7% | 3.0% | ||
| Q1 25 | 0.6% | 7.6% | ||
| Q4 24 | 0.8% | 1.9% | ||
| Q3 24 | 0.4% | 2.8% | ||
| Q2 24 | 0.8% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
ICHR
Segment breakdown not available.
